SG Americas Securities LLC grew its holdings in shares of Cutera, Inc. (NASDAQ:CUTR) by 945.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 40,006 shares of the medical device company’s stock after purchasing an additional 36,180 shares during the quarter. SG Americas Securities LLC owned approximately 0.29% of Cutera worth $1,302,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Piedmont Investment Advisors LLC bought a new position in shares of Cutera during the 2nd quarter valued at approximately $128,000. United Services Automobile Association bought a new position in shares of Cutera during the 2nd quarter valued at approximately $208,000. Assenagon Asset Management S.A. bought a new position in shares of Cutera during the 3rd quarter valued at approximately $263,000. Los Angeles Capital Management & Equity Research Inc. bought a new position in shares of Cutera during the 2nd quarter valued at approximately $347,000. Finally, Navellier & Associates Inc bought a new position in shares of Cutera during the 2nd quarter valued at approximately $351,000.
Shares of NASDAQ:CUTR opened at $18.13 on Friday. Cutera, Inc. has a 12-month low of $17.94 and a 12-month high of $56.05.
Cutera (NASDAQ:CUTR) last posted its quarterly earnings results on Tuesday, November 6th. The medical device company reported $0.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.08. Cutera had a negative return on equity of 0.50% and a net margin of 11.16%. The business had revenue of $40.60 million during the quarter, compared to the consensus estimate of $40.03 million. During the same period in the prior year, the company posted $0.42 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, research analysts predict that Cutera, Inc. will post -0.29 earnings per share for the current fiscal year.
A number of research analysts recently issued reports on CUTR shares. ValuEngine upgraded Cutera from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st. Sidoti set a $50.00 price objective on Cutera and gave the company a “buy” rating in a research note on Friday, October 5th. BidaskClub downgraded Cutera from a “buy” rating to a “hold” rating in a research note on Thursday, September 20th. Zacks Investment Research upgraded Cutera from a “strong sell” rating to a “hold” rating in a research note on Wednesday. Finally, Stifel Nicolaus cut their price objective on Cutera from $45.00 to $29.00 and set a “hold” rating for the company in a research note on Friday, October 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. Cutera has a consensus rating of “Hold” and a consensus target price of $39.24.
TRADEMARK VIOLATION WARNING: “SG Americas Securities LLC Grows Stake in Cutera, Inc. (CUTR)” was reported by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/12/08/sg-americas-securities-llc-grows-stake-in-cutera-inc-cutr.html.
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Recommended Story: Initial Public Offering (IPO)
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.